Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

General disorders and administration site conditions

  • 140 clinical trials
  • 57 recruiting
  • 120 conditions
  • 23 countries

Conditions in this area

120 conditions with trials, the busiest first

Procedural pain29Pain21Critical illness18Medical device site joint infection8Inflammation7Still's disease6Chronic fatigue syndrome5Friedreich's ataxia5Cachexia4Device related infection4Hereditary ataxia4Hot flush4Postoperative analgesia4Anxiety2Colorectal cancer2Delirium tremens2Diabetic neuropathy2Febrile neutropenia2Hip arthroplasty2Juvenile idiopathic arthritis2Menopausal symptoms2Neuropathy peripheral2Parkinson's disease2Pyrexia2+96

Clinical trials in General disorders and administration site conditions

140 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

140 clinical trials

Cachexia

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:VISUGROMAB
  • Sponsor:CatalYm GmbH

Colorectal cancer+1

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST GDNF FAMILY RECEPTOR ALPHA-LIKE
  • Sponsor:Ngm Biopharmaceuticals Inc.

Inflammatory bowel disease+1

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Modafinil
  • Sponsor:Stichting Radboud universitair medisch centrum

Vitamin D deficiency+1

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colecalciferol
  • Sponsor:Medical University Of Graz

Endometrial cancer+12

Recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Friedreich's ataxia

Recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Omaveloxolone
  • Sponsor:Fakultni Nemocnice V Motole

Acute kidney injury+2

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:MALIC ACID
  • Sponsor:Universitaet Muenster

Pain+3

Recruiting
Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ibuprofen
  • Sponsor:Aft Pharmaceuticals Limited

Still's disease+1

Recruiting
InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years
  • Substances:Apremilast
  • Sponsor:Amgen Inc.

Still's disease

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Human Igg1 Monoclonal Antibody Against Human Il-1 Beta And Human Il-18
  • Sponsor:Novartis Pharma AG

Device related infection+1

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Region Midtjylland

Pain

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nefopam Hydrochloride
  • Sponsor:Centre Hospitalier Universitaire Rouen

Substances studied in this area

The therapies tested most often in General disorders and administration site conditions trials.

Sodium Chloride18 clinical trialsParacetamol10 clinical trialsIbuprofen5 clinical trialsLidocaine Hydrochloride5 clinical trialsPlacebo5 clinical trialsRifampicin5 clinical trialsLidocaine Hydrochloride Monohydrate4 clinical trialsLinezolid4 clinical trialsPiperacillin4 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.